Evidence map›Paper›PMID 33801069›Full record

ReviewBrain sciences2021

Inherited Neuromuscular Disorders: Which Role for Serum Biomarkers?

Antonino Lupica, Vincenzo Di Stefano, Andrea Gagliardo, Salvatore Iacono, Antonia Pignolo, Salvatore Ferlisi, Angelo Torrente, Sonia Pagano, Massimo Gangitano, Filippo Brighina

Open access · goldAbstract readReview
In one paragraph

Review in Brain sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. X-linked myopathy with excessive autophagy due to a mutation in VMA21 gene: the first case in China.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Article
  6. A novel compound heterozygous mutation in PYGM gene associated with McArdle's disease.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Antonino LupicaDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.ORCID 0000-0003-1499-9460
Vincenzo Di StefanoDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.ORCID 0000-0001-9805-1655
Andrea GagliardoDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.
Salvatore IaconoDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.ORCID 0000-0003-0035-5859
Antonia PignoloDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.ORCID 0000-0002-8883-5701
Salvatore FerlisiDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.
Angelo TorrenteDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.ORCID 0000-0002-0585-8351
Sonia PaganoDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.
Massimo GangitanoDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.
Filippo BrighinaDepartment of Biomedicine, Neuroscience and advanced Diagnostic (BIND), University of Palermo, 90121 Palermo, Italy.
University of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inherited neuromuscular disorders (INMD) are a heterogeneous group of rare diseases that involve muscles, motor neurons, peripheral nerves or the neuromuscular junction. Several different lab abnormalities have been linked to INMD: sometimes they are typical of the disorder, but they usually appear to be less specific. Sometimes serum biomarkers can point out abnormalities in presymtomatic or otherwise asymptomatic patients (e.g., carriers). More often a biomarker of INMD is evaluated by multiple clinicians other than expert in NMD before the diagnosis, because of the multisystemic involvement in INMD. The authors performed a literature search on biomarkers in inherited neuromuscular disorders to provide a practical approach to the diagnosis and the correct management of INMD. A considerable number of biomarkers have been reported that support the diagnosis of INMD, but the role of an expert clinician is crucial. Hence, the complete knowledge of such abnormalities can accelerate the diagnostic workup supporting the referral to specialists in neuromuscular disorders.

Indexed as

biomarkersinherited neuromuscular disordersrare diseases

Identifiers

PMID33801069
PMCPMC8004068
OpenAlexW3138138929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.